Le Lézard

News by subject: HEALTH

1 2 3 4 5 6 7 8 9 10 11 12 13

16 january 2024

10:00
January is Alzheimer's Awareness Month, recognised across Canada and internationally as an opportunity to reflect on the challenges faced by the growing number of people living with dementia, and their care partners. To underscore the urgency of this...


15 january 2024

13:05
Bow Valley College and partner Calgary Region Immigrant Employment Council (CRIEC) have received a $9.4 million grant from the Government of Canada to help Internationally Educated Nurses (IENs) gain employment in Canada.  Employment and Social...


11 january 2024

09:40
Who says eating healthy has to be boring? The Chopped Leaf is here to spice up your new year and help you achieve your 2024 healthy-eating goals like never before. The star of the show is The Chopped Leaf's fan-favorite Bangkok Bowl, which is...

08:30
NetworkNewsAudio ? Lexaria Bioscience Corp. announces the availability of a broadcast titled, "Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs." To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast To...

07:30
Salona Global Medical Device Corporation (the ???"Company") ??, announced today it has executed an exclusive distribution agreement with Veteran Medical Solutions, LLC ("VMS"), a U.S. military veteran owned company that is positioned to sell the...

07:00
First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears                Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces...

06:00
Today, TELUS Health, a global leader in health technology, and Clinia, a leading provider of health-grade search technologies have announced an exclusive strategic partnership to revolutionize...


10 january 2024

11:45
LifeLabs is proud to announce our achievement for the second consecutive year ? securing the 2024 BrandSpark Most Trusted Brand Award in Health Diagnostic Services. "In the ever-evolving landscape of healthcare, this back-to-back win is a...


9 january 2024

08:30
via InvestorWire ? Lexaria Bioscience Corp. today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform...

08:05
Organovo Holdings, Inc. , a clinical stage biotechnology company that is focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human...

07:00
The ABILITY-1 Study will evaluate MDNA11, a highly selective long-acting IL-2 Superkine, in combination with KEYTRUDA® (pembrolizumab) for treatment of patients with advanced solid tumorsMDNA11 continues to demonstrate encouraging single-agent...


8 january 2024

07:00
LSL Pharma Group Inc. ? (the "Company" or "LSL Pharma Group"), a Canadian integrated pharmaceutical company, announces that it extends until February 7, 2024 its brokered private placement through the issuance of unsecured convertible debentures at...


4 january 2024

08:00
Recursion , a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed an agreement with Bayer AG to in-license a new chemical entity that emerged from the companies' fibrosis research...

07:30
Knight Therapeutics Inc., ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of IMVEXXY® in Canada. IMVEXXY® (estradiol vaginal inserts) is approved for the treatment of postmenopausal moderate to severe...

07:00
Preliminary total 4Q and full year 2023 net product revenue of $71 million and $204 million, respectively Auvelity preliminary 4Q and full year 2023 net product sales of $49 million and $130 million, respectively Sunosi preliminary 4Q and full year...

06:15
Company well-positioned for further progress and broadening of R&D pipelineCash resources of approximately $455 million as of December 31, 2023 (unaudited)Expected cash runway, including proceeds from recent private placement, into 2H 2027Top-line...

06:00
Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today...

05:00
Adagene Inc. ("Adagene") , a company transforming the discovery and development of novel antibody-based therapies, today announced a poster presentation...


3 january 2024

12:40
Calgary Health Foundation Board Vice Chair Sarah Kennedy has been appointed as Interim Board Chair. Sarah has been a dedicated member of the Board for 11 years, providing thoughtful leadership as Vice Chair over the past four years. "We are...

07:30
Optimi Health Corp. (FRA: 8BN) ("Optimi"), a Health Canada licensed drug researcher and formulator specializing in controlled psychedelic substances such as natural psilocybin and MDMA, proudly announces a significant milestone in the granting of...

07:30
HydroGraph Clean Power Inc. (the "Company" or "HydroGraph"), a commercial manufacturer of high-quality nanomaterials, announced today that its flagship graphene product, FGA-1, has been successfully trialed in Hawkeye Bio's biomedical sensor aimed...

05:00
OBI Pharma, a clinical stage oncology company (4174.TWO), today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for OBI-992, to conduct a Phase 1/2 study of its novel antibody -...


2 january 2024

13:20
A diagnosis of dementia is not easy. During National Alzheimer's Awareness Month in January, the ALZHEIMER SOCIETY OF ALBERTA AND NORTHWEST TERRITORIES connects people living with dementia and their care partners with free support, knowledge, and a...

08:00
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the...

07:30
Trogarzo® IM maintenance dosing aims to further enhance the convenience of non-oral therapy for heavily treatment-experienced adults with HIV Submission comes on the heels of the recent FDA approval of the Trogarzo® IV push loading dose    This news...


29 december 2023

18:15
Cell BioEngines, Inc., a clinical-stage biotechnology company focused on delivering novel, innovative stem cell and immune cell therapies to address blood and solid cancers, today announced an agreement with Miltenyi to develop and manufacture its...


27 december 2023

17:00
Quipt Home Medical Corp. (the "Company") , a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that it has filed a preliminary short form base shelf prospectus (the "Shelf Prospectus") with the...

16:05
Algernon Pharmaceuticals Inc.  (the "Company" or "Algernon") a Canadian clinical stage pharmaceutical development company announces the close of its non-brokered private placement, previously announced on December 12, 2023 and updated on December...


21 december 2023

13:40
It was a year of fast and furious activity for Bow Valley College. Did you blink? Then, you may have missed some of the excitement. Join us for a trip back in time as we look at the greatest Bow Valley College moments and stories of 2023.  The...


20 december 2023

14:50
We are thrilled to announce that Charles Brown, the President and CEO of LifeLabs, has been honoured with the prestigious Leadership Excellence in Medical Diagnostics and Laboratory Testing in the 2023 CEO Healthcare Awards, presented by CEO Today...


19 december 2023

09:30
December 19, 2023Amsterdam, the Netherlands ? Royal Philips  today announced that it has completed the cancellation of 15,134,054 of its shares. The cancelled shares were acquired as part of the EUR 1.5 billion share repurchase program for capital...

07:05
Proceeds will support lead precision oncology program into the clinic and advance earlier stage pipelineAtavistik Bio is discovering transformative precision allosteric small molecule therapeutics for genetically validated targets by leveraging the...


18 december 2023

07:30
Lantheus Holdings, Inc. (Lantheus) and POINT Biopharma Global Inc. (POINT) today announced statistically significant topline results from the pivotal phase 3 SPLASH study evaluating the efficacy and safety of 177Lu-PNT2002, a prostate-specific...


15 december 2023

17:20
Extendicare Inc. ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.04 per common share of the Company (the "Common Share") for the month of December 2023, which is payable on January 15, 2024 to shareholders of...

09:10
Biogen Inc. announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended marketing authorization for SKYCLARYS® (omaveloxolone) for the...


14 december 2023

11:30
The holidays are not so merry and bright for millions of people in Canada. Holiday depression and anxiety, along with loneliness, can mean trying days for so many at this time of year. Ontario Shores Centre for Mental Health Sciences (Ontario...

07:00
Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, announces a collaboration with Seegene USA, Inc. ("Seegene USA"), a leading developer of multiplex molecular assays and automated solutions for U.S. labs. Under the...

06:30
Biogen Inc. and Sage...


13 december 2023

07:30
Updated label means new Trogarzo® patients no longer require initiation of treatment by 30-minute infusionComplete IV push method enables easier and more convenient administration of Trogarzo® for heavily treatment-experienced adults with HIV This...

07:25
Arch Biopartners Inc., ("Arch" or the "Company") , announced today it has submitted a Clinical Trial Application to Health Canada to obtain permission to proceed with a Phase II trial for LSALT peptide, targeting the prevention and treatment of...

03:05
Reliq Health Technologies Inc. ("Reliq" or the "Company"), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has...


12 december 2023

19:45
Algernon Pharmaceuticals Inc.  (the "Company" or "Algernon") a Canadian clinical stage pharmaceutical development company announces a non-brokered private placement for gross proceeds of $150,000 (the "Offering") of units (the "Units") at an issue...


11 december 2023

17:20
Reliq Health Technologies Inc. ("Reliq" or the "Company"), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announces that it has accepted...

12:50
After today's announcement that eligible seniors will be invited to apply for enrollment in the Canadian Dental Care Plan (CDCP) starting this month, and care could begin as early as May 2024, many questions remain. It is unclear how this new program...

07:00
Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for...

04:00
London, UK ? December 11, 2023 ? OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is excited to announce a strategic collaboration with Nested...


7 december 2023

07:30
Optimi Health Corp. (FRA: 8BN) ("Optimi"), a licensed Canadian drug researcher and formulator specializing in controlled psychedelic substances such as natural psilocybin and MDMA, today announced the signing of a supply agreement with Sunshine...


6 december 2023

16:35
LifeLabs, Canada's leading provider of medical diagnostic services, is proud to unveil the 2022 Community Report titled "Committed to Care." This report highlights the incredible journey of our dedicated team over the past year, exemplifying our...


5 december 2023

11:20
Thornhill Medical announced today that it is participating in a pilot project which aims to increase medical surge capabilities and capacity of the U.S. National Disaster Medical System (NDMS). Funded by the Defense Health Agency (DHA), the pilot...


4 december 2023

22:45
Moleac announced promising results from the SAMURAI double-blind study in patients with mild traumatic brain injury (mTBI) receiving a 6-month course of NeuroAiDtmII. In the study, the NeuroAiDtmII group showed significant improvement in their...

1 2 3 4 5 6 7 8 9 10 11 12 13